TLCC — Twinlab Consolidated Holdings Share Price
0.000.00%
Last trade - 00:00- $0.13m
- $92.76m
- $13.62m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 0.05 | ||
| Price to Sales | 0.01 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -6.69% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 73.46 | 66.35 | 72.09 | 17.21 | 13.62 | n/a | n/a | -28.58% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Twinlab Consolidated Holdings, Inc. is a marketer, distributor and direct-to-consumer retailer of branded nutritional supplements and other natural products sold to and through domestic health and natural food stores, mass market retailers, specialty store retailers, on-line retailers, and websites. Internationally, the Company markets and distributes branded nutritional supplements and other natural products to and through health and natural product distributors and retailers. Through NutraScience Labs, it also provides services between private label distributors and contract manufacturers. Its services business involved the facilitation of manufacture of custom products. Its products include vitamins, minerals, resveratrol, collagen, keratin, skincare and sports nutrition products primarily under the Twinlab, Reserveage and ResVitale brands. It also markets and sells diet and energy products under the Metabolife brand and a full line of herbal teas under the Alvita brand.
Directors
- David Van Andel NEC (60)
- Dan Dipofi CEO (59)
- Kyle Casey CFO (37)
- Craig Fabel DRC (51)
- Anthony Zolezzi DRC (67)
- Seth Ellison IND (64)
- B. Thomas Golisano IND (79)
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- October 24th, 2013
- Public Since
- June 25th, 2014
- No. of Shareholders
- 375
- No. of Employees
- 17
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 259,092,833
- Address
- 4800 T-Rex Avenue, Suite 305, BOCA RATON, 33431
- Web
- https://www.tchhome.com/
- Phone
- +1 5614435001
- Auditors
- Tanner LLC
Upcoming Events for TLCC
Q1 2025 Twinlab Consolidated Holdings Inc Earnings Release
Q2 2025 Twinlab Consolidated Holdings Inc Earnings Release
Similar to TLCC
Adia Nutrition
Pink Sheets on Nasdaq
African Agriculture Holdings
Pink Sheets on Nasdaq
Agri-Dynamics
Pink Sheets on Nasdaq
Agristar
Pink Sheets on Nasdaq
Aifarm
Pink Sheets on Nasdaq
FAQ
What is the Twinlab Consolidated Holdings share price?
As of Today at 23:50 UTC, shares in Twinlab Consolidated Holdings are trading at $0.00. This share price information is delayed by 15 minutes.
How has the Twinlab Consolidated Holdings share price performed this year?
Shares in Twinlab Consolidated Holdings last closed at $0.00 and the price had moved by -94.67% over the past 365 days. In terms of relative price strength the Twinlab Consolidated Holdings share price has underperformed the S&P500 Index by -95.02% over the past year.
What are the analyst and broker recommendations for Twinlab Consolidated Holdings?
There is no consensus recommendation for this security.
Find out moreWhat is the Twinlab Consolidated Holdings dividend yield?
Twinlab Consolidated Holdings does not currently pay a dividend.
Does Twinlab Consolidated Holdings pay a dividend?
Twinlab Consolidated Holdings does not currently pay a dividend.
When does Twinlab Consolidated Holdings next pay dividends?
Twinlab Consolidated Holdings does not currently pay a dividend.
How do I buy Twinlab Consolidated Holdings shares?
To buy shares in Twinlab Consolidated Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Twinlab Consolidated Holdings?
As of the previous close price of $0.00, shares in Twinlab Consolidated Holdings had a market capitalisation of $0.13m.
Where are Twinlab Consolidated Holdings shares listed?
Here are the trading details for Twinlab Consolidated Holdings:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: TLCC
What kind of share is Twinlab Consolidated Holdings?
Based on an overall assessment of its quality, value and momentum Twinlab Consolidated Holdings is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Twinlab Consolidated Holdings share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Twinlab Consolidated Holdings share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Twinlab Consolidated Holdings. Over the past six months, its share price has underperformed the S&P500 Index by -96.54%.
As of the last closing price of $0.00, shares in Twinlab Consolidated Holdings were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Twinlab Consolidated Holdings PE Ratio?
The Twinlab Consolidated Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Twinlab Consolidated Holdings?
Twinlab Consolidated Holdings' management team is headed by:
- David Van Andel - NEC
- Dan Dipofi - CEO
- Kyle Casey - CFO
- Craig Fabel - DRC
- Anthony Zolezzi - DRC
- Seth Ellison - IND
- B. Thomas Golisano - IND